|
|
|
29 May 2008 |
Wyeth Receives FDA Fast Track Designation for its 13-valent Pneumococcal Conjugate Vaccine for Infants and Toddlers
|
|
28 May 2008 |
Juvaris BioTherapeutics Initiates Phase I Clinical Trial of JVRS-100 Adjuvnated Seasonal Influenza Vaccine
|
|
28 May 2008 |
Bharat Biotech Announces Successful Completion Of Its Phase I/II Clinical Trial For 116E Rotavirus Vaccine
|
|
27 May 2008 |
Bavarian Nordic enters clinical trials with HIV multiantigen vaccine
|
|
27 May 2008 |
Favrille Announces Results from Phase 3 Registration Trial of Specifid in Patients with Follicular B-Cell Non-Hodgkin's Lymphoma
|
|
19 May 2008 |
First pre-pandemic vaccine approved to help protect against pandemic influenza
|
|
16 May 2008 |
Dynavax TOLAMBA(TM) Chamber Study Misses Primary Endpoint; Company Updates 2008 Financial Outlook
|
|
15 May 2008 |
Novavax completes enrollment in phase 1/IIa pandemic influenza vaccine clinical trial
|
|
14 May 2008 |
In a Phase II study, Novartis Meningitis B vaccine has potential to produce a protective immune response in infants[1], the age group most at risk
|
|
12 May 2008 |
Nventa announces additional positive immunological data from HSPE7 phase 1 Cervical Dysplasia trial
|
|
09 May 2008 |
Dutch Authorize Manufacture of Vaccinogen’s New Cancer Vaccine
|
|
06 May 2008 |
Novartis Menveo(R) vaccine shows superior immune response against four types of meningitis disease in pivotal phase III trial
|
|
29 Apr 2008 |
Quantum Immunologics, Inc. and the South Alabama Medical Science Foundation Announce an Early Clinical Evaluation of a Novel Immuno-therapeutic Vaccine for Treating Advanced Human Breast Carcinomas
|
|
29 Apr 2008 |
DOR BioPharma Initiates Non-Human Primate Efficacy Studies of RiVaxTM, Its Vaccine Against Ricin Toxin
|
|
22 Apr 2008 |
Biovex agrees SPA with the FDA for a pivotal study with ONCOVEXGM-CSF in metastatic melanoma and announces presentation of phase II results at ASCO
|
|
17 Apr 2008 |
Alphavax announces initial analysis of data from CMV phase I clinical trial
|
|
17 Apr 2008 |
Dynavax and Merck & Co., Inc. Update Status of Clinical Hold of Investigational Vaccine HEPLISAV(TM)
|
|
16 Apr 2008 |
Pfizer and AVANT Enter into Licensing and Development Agreement for Novel Therapeutic Vaccine Candidate for Brain Cancer
|
|
16 Apr 2008 |
Novavax Reports Positive Results from Preclinical Studies of its VLP-based
|
|
15 Apr 2008 |
Iomai Receives HHS Approval to Begin Phase 2 Trial of H5N1 Influenza Adjuvant Patch
|
|
14 Apr 2008 |
Cell Genesys Reports Preclinical Data Demonstrating Superior Anti-Tumor Immunity for Multiantigen Compared to Single-Antigen Immunotherapies
|
|
11 Apr 2008 |
Cell Genesys Announces Encouraging Results from Phase 1/2 Trial of GVAX Immunotherapy for Prostate Cancer in Recurrent Disease
|
|
10 Apr 2008 |
Post-exposure vaccination with IMVAMUNE(R) protects against lethal poxvirus infection
|
|
09 Apr 2008 |
Aeras, Crucell and South African Tuberculosis Vaccine Initiative Announce Encouraging Preliminary Results of Tuberculosis Vaccine Clinical Trial in South Africa
|
|
08 Apr 2008 |
Oncophage(R) Approved in Russia for the Treatment of Intermediate-Risk Kidney Cancer
|
|
04 Apr 2008 |
Prostate Cancer DNA Vaccine Results in Higher T-Cell Response When Delivered via Inovio Biomedical's Electroporation Delivery System
|
|
04 Apr 2008 |
FDA Approves ROTARIX(R) Rotavirus Vaccine
|
|
03 Apr 2008 |
Crucell Announces First in Man Study with New Adenovirus Vector
|
|
03 Apr 2008 |
Iomai and Merck & Co., Inc. Evaluate Use of Iomai Immunostimulant Patch
|
|
02 Apr 2008 |
Yondelis (R) has been granted orphan drug status by the swiss agency for therapeutic products (Swissmedic) for the treatment of soft tissue sarcoma and ovarian cancer
|
|
02 Apr 2008 |
Sinovac Biotech Ltd. (SNVBF) Receives SFDA Approval for Pandemic Influenza H5N1 Vaccine
|
|
01 Apr 2008 |
AVANT's Single-Dose Oral Ty800 Vaccine Meets Primary Endpoints in Phase 2 Study
|
|
31 Mar 2008 |
Cell Genesys and Takeda Announce Global Alliance for the Development and Commercialization of GVAX Immunotherapy for Prostate Cancer
|
|
31 Mar 2008 |
Sharing of Sabin-IPV Seed Virus by Japan Poliomyelitis Research Institute with Takeda and Grant of Right to Its Commercialization
|
|
25 Mar 2008 |
Oxford BioMedica Report Encouraging New Phase II Trial Results With TroVax(R) in Prostate Cancer
|
|
20 Mar 2008 |
Acambis extends Sanofi Pasteur licensing agreement on single-dose JE vaccine to India and Indian subcontinent
|
|
20 Mar 2008 |
Study Finds Single Dose of Iomai Patch With Pandemic Flu Vaccine Achieves Protective Levels
|
|
20 Mar 2008 |
Pharmathene signs definitive agreement to acquire Biodefense vaccines business from Avecia
|
|
19 Mar 2008 |
Medicago’s H5N1 VLP vaccine provides protection against multiple strains of avian flu
|
|
19 Mar 2008 |
GlobeImmune Announces Initiation of a Phase 2a Clinical Trial of GI-4000 in Patients with Non-Small Cell Lung Cancer at Memorial Sloan Kettering
|
|
17 Mar 2008 |
ALK-Abelló, the makers of GRAZAX(R), Present Successful Phase III Clinical Study Results with Children
|
|
17 Mar 2008 |
Dynavax and Merck & Co., Inc. Report Clinical Hold of Investigational Vaccine HEPLISAV
|
|
17 Mar 2008 |
Hepatitis C Virus DNA Vaccine Shows Safety When Delivered by Inovio Biomedical's Electroporation Delivery System in Phase I/II Clinical Study at Karolinska University Hospital
|
|
14 Mar 2008 |
Greer Reports Favorable Results of Phase IIb Clinical Trial of Short Ragweed Sublingual-Oral Immunotherapy at American Academy of Allergy Asthma and Immunology Annual Meeting
|
|
14 Mar 2008 |
Diamyd Gets Authorization to Begin Phase III Study in the US
|
|
11 Mar 2008 |
Opexa Therapeutics Announces Completion of Mid Study DescriptiveAnalysis on Phase IIb Trial of Tovaxin(R) for Treatment of Multiple Sclerosis
|
|
11 Mar 2008 |
Inovio Biomedical's Electroporation Delivery Technology Demonstrates Safety and Positive Clinical Responses with Melanoma DNA Immunotherapy
|
|
11 Mar 2008 |
Nventa Enrolls and Initiates Dosing of Final Cohort in HSPE7 Phase 1 Cervical Dysplasia Trial
|
|
10 Mar 2008 |
Oxford Biomedica completes patient recruitment for Phase III trist study of Trovax (R) in renal cancer
|
|
10 Mar 2008 |
Genitope Corporation to Suspend Development of MyVax(R) Personalized Immunotherapy
|
| |
|
Results 51 - 100 of 599 |
